Alpha-2 adrenergic receptor (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Alpha-2 adrenergic receptor" in English language version.

refsWebsite

Global rank English rank

23nih.gov

4^th place

16doi.org

2^nd place

3web.archive.org

1^st place

2semanticscholar.org

11^th place

8^th place

1medscape.org

low place

1aspetjournals.org

6,663^rd place

5,792^nd place

1unc.edu

1,538^th place

1,042^nd place

1webmd.com

1,169^th place

1,075^th place

1europa.eu

68^th place

117^th place

1online-medical-dictionary.org

low place

aspetjournals.org

jpet.aspetjournals.org

Millan MJ, Cussac D, Milligan G, Carr C, Audinot V, Gobert A, et al. (June 2001). "Antiparkinsonian agent piribedil displays antagonist properties at native, rat, and cloned, human alpha(2)-adrenoceptors: cellular and functional characterization". The Journal of Pharmacology and Experimental Therapeutics. 297 (3): 876–887. PMID 11356907. Archived from the original on 2019-12-14. Retrieved 2013-08-21.

doi.org

Ruuskanen JO, Xhaard H, Marjamäki A, Salaneck E, Salminen T, Yan YL, et al. (January 2004). "Identification of duplicated fourth alpha2-adrenergic receptor subtype by cloning and mapping of five receptor genes in zebrafish". Molecular Biology and Evolution. 21 (1): 14–28. doi:10.1093/molbev/msg224. PMID 12949138.
Saunders C, Limbird LE (November 1999). "Localization and trafficking of alpha2-adrenergic receptor subtypes in cells and tissues". Pharmacology & Therapeutics. 84 (2): 193–205. doi:10.1016/S0163-7258(99)00032-7. PMID 10596906.
Khan ZP, Ferguson CN, Jones RM (February 1999). "alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role". Anaesthesia. 54 (2): 146–165. doi:10.1046/j.1365-2044.1999.00659.x. PMID 10215710.
Wang M, Ramos BP, Paspalas CD, Shu Y, Simen A, Duque A, et al. (April 2007). "Alpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex". Cell. 129 (2): 397–410. doi:10.1016/j.cell.2007.03.015. PMID 17448997.
Arnsten AF (December 2020). "Guanfacine's mechanism of action in treating prefrontal cortical disorders: Successful translation across species". Neurobiology of Learning and Memory. 176: 107327. doi:10.1016/j.nlm.2020.107327. PMC 7567669. PMID 33075480.
Woodman OL, Vatner SF (August 1987). "Coronary vasoconstriction mediated by alpha 1- and alpha 2-adrenoceptors in conscious dogs". The American Journal of Physiology. 253 (2 Pt 2): H388 – H393. doi:10.1152/ajpheart.1987.253.2.H388. PMID 2887122.
Sun D, Huang A, Mital S, Kichuk MR, Marboe CC, Addonizio LJ, et al. (July 2002). "Norepinephrine elicits beta2-receptor-mediated dilation of isolated human coronary arterioles". Circulation. 106 (5): 550–555. doi:10.1161/01.CIR.0000023896.70583.9F. PMID 12147535.
Elliott J (August 1997). "Alpha-adrenoceptors in equine digital veins: evidence for the presence of both alpha1 and alpha2-receptors mediating vasoconstriction". Journal of Veterinary Pharmacology and Therapeutics. 20 (4): 308–317. doi:10.1046/j.1365-2885.1997.00078.x. PMID 9280371.
Sagrada A, Fargeas MJ, Bueno L (August 1987). "Involvement of alpha-1 and alpha-2 adrenoceptors in the postlaparotomy intestinal motor disturbances in the rat". Gut. 28 (8): 955–959. doi:10.1136/gut.28.8.955. PMC 1433140. PMID 2889649.
Wright EE, Simpson ER (November 1981). "Inhibition of the lipolytic action of beta-adrenergic agonists in human adipocytes by alpha-adrenergic agonists". Journal of Lipid Research. 22 (8): 1265–1270. doi:10.1016/S0022-2275(20)37319-3. PMID 6119348.
Qin K, Sethi PR, Lambert NA (August 2008). "Abundance and stability of complexes containing inactive G protein-coupled receptors and G proteins". FASEB Journal. 22 (8): 2920–2927. doi:10.1096/fj.08-105775. PMC 2493464. PMID 18434433.
Haenisch B, Walstab J, Herberhold S, Bootz F, Tschaikin M, Ramseger R, et al. (December 2010). "Alpha-adrenoceptor agonistic activity of oxymetazoline and xylometazoline". Fundamental & Clinical Pharmacology. 24 (6): 729–739. doi:10.1111/j.1472-8206.2009.00805.x. PMID 20030735. S2CID 25064699.
Young R (2007). "TDIQ (5,6,7,8-tetrahydro-1,3-dioxolo [4,5-g]isoquinoline): discovery, pharmacological effects, and therapeutic potential". CNS Drug Reviews. 13 (4): 405–422. doi:10.1111/j.1527-3458.2007.00022.x. PMC 6494129. PMID 18078426.
Gobert A, Di Cara B, Cistarelli L, Millan MJ (April 2003). "Piribedil enhances frontocortical and hippocampal release of acetylcholine in freely moving rats by blockade of alpha 2A-adrenoceptors: a dialysis comparison to talipexole and quinelorane in the absence of acetylcholinesterase inhibitors". The Journal of Pharmacology and Experimental Therapeutics. 305 (1): 338–346. doi:10.1124/jpet.102.046383. PMID 12649387. S2CID 29234876.
Crassous PA, Cardinaletti C, Carrieri A, Bruni B, Di Vaira M, Gentili F, et al. (August 2007). "Alpha2-adrenoreceptors profile modulation. 3.1 (R)-(+)-m-nitrobiphenyline, a new efficient and alpha2C-subtype selective agonist". Journal of Medicinal Chemistry. 50 (16): 3964–3968. doi:10.1021/jm061487a. PMID 17630725.
Del Bello F, Mattioli L, Ghelfi F, Giannella M, Piergentili A, Quaglia W, et al. (November 2010). "Fruitful adrenergic α(2C)-agonism/α(2A)-antagonism combination to prevent and contrast morphine tolerance and dependence". Journal of Medicinal Chemistry. 53 (21): 7825–7835. doi:10.1021/jm100977d. PMID 20925410.

europa.eu

emea.europa.eu

"EPAR summary for the public: Dexdomitor" (PDF). www.ema.europa.eu/ema/. European Medicines Agency. Retrieved July 22, 2017.

medscape.org

Arnsten AF (26 July 2007). "Alpha-2 Agonists in the Treatment of ADHD". Medscape Psychiatry. WebMD. Retrieved 13 November 2013.

nih.gov

pubmed.ncbi.nlm.nih.gov

Ruuskanen JO, Xhaard H, Marjamäki A, Salaneck E, Salminen T, Yan YL, et al. (January 2004). "Identification of duplicated fourth alpha2-adrenergic receptor subtype by cloning and mapping of five receptor genes in zebrafish". Molecular Biology and Evolution. 21 (1): 14–28. doi:10.1093/molbev/msg224. PMID 12949138.
Saunders C, Limbird LE (November 1999). "Localization and trafficking of alpha2-adrenergic receptor subtypes in cells and tissues". Pharmacology & Therapeutics. 84 (2): 193–205. doi:10.1016/S0163-7258(99)00032-7. PMID 10596906.
Khan ZP, Ferguson CN, Jones RM (February 1999). "alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role". Anaesthesia. 54 (2): 146–165. doi:10.1046/j.1365-2044.1999.00659.x. PMID 10215710.
U'Prichard DC, Bechtel WD, Rouot BM, Snyder SH (July 1979). "Multiple apparent alpha-noradrenergic receptor binding sites in rat brain: effect of 6-hydroxydopamine". Molecular Pharmacology. 16 (1): 47–60. PMID 39248.
Wang M, Ramos BP, Paspalas CD, Shu Y, Simen A, Duque A, et al. (April 2007). "Alpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex". Cell. 129 (2): 397–410. doi:10.1016/j.cell.2007.03.015. PMID 17448997.
Arnsten AF (December 2020). "Guanfacine's mechanism of action in treating prefrontal cortical disorders: Successful translation across species". Neurobiology of Learning and Memory. 176: 107327. doi:10.1016/j.nlm.2020.107327. PMC 7567669. PMID 33075480.
Woodman OL, Vatner SF (August 1987). "Coronary vasoconstriction mediated by alpha 1- and alpha 2-adrenoceptors in conscious dogs". The American Journal of Physiology. 253 (2 Pt 2): H388 – H393. doi:10.1152/ajpheart.1987.253.2.H388. PMID 2887122.
Sun D, Huang A, Mital S, Kichuk MR, Marboe CC, Addonizio LJ, et al. (July 2002). "Norepinephrine elicits beta2-receptor-mediated dilation of isolated human coronary arterioles". Circulation. 106 (5): 550–555. doi:10.1161/01.CIR.0000023896.70583.9F. PMID 12147535.
Elliott J (August 1997). "Alpha-adrenoceptors in equine digital veins: evidence for the presence of both alpha1 and alpha2-receptors mediating vasoconstriction". Journal of Veterinary Pharmacology and Therapeutics. 20 (4): 308–317. doi:10.1046/j.1365-2885.1997.00078.x. PMID 9280371.
Sagrada A, Fargeas MJ, Bueno L (August 1987). "Involvement of alpha-1 and alpha-2 adrenoceptors in the postlaparotomy intestinal motor disturbances in the rat". Gut. 28 (8): 955–959. doi:10.1136/gut.28.8.955. PMC 1433140. PMID 2889649.
Wright EE, Simpson ER (November 1981). "Inhibition of the lipolytic action of beta-adrenergic agonists in human adipocytes by alpha-adrenergic agonists". Journal of Lipid Research. 22 (8): 1265–1270. doi:10.1016/S0022-2275(20)37319-3. PMID 6119348.
Qin K, Sethi PR, Lambert NA (August 2008). "Abundance and stability of complexes containing inactive G protein-coupled receptors and G proteins". FASEB Journal. 22 (8): 2920–2927. doi:10.1096/fj.08-105775. PMC 2493464. PMID 18434433.
Haenisch B, Walstab J, Herberhold S, Bootz F, Tschaikin M, Ramseger R, et al. (December 2010). "Alpha-adrenoceptor agonistic activity of oxymetazoline and xylometazoline". Fundamental & Clinical Pharmacology. 24 (6): 729–739. doi:10.1111/j.1472-8206.2009.00805.x. PMID 20030735. S2CID 25064699.
Young R (2007). "TDIQ (5,6,7,8-tetrahydro-1,3-dioxolo [4,5-g]isoquinoline): discovery, pharmacological effects, and therapeutic potential". CNS Drug Reviews. 13 (4): 405–422. doi:10.1111/j.1527-3458.2007.00022.x. PMC 6494129. PMID 18078426.
Millan MJ, Cussac D, Milligan G, Carr C, Audinot V, Gobert A, et al. (June 2001). "Antiparkinsonian agent piribedil displays antagonist properties at native, rat, and cloned, human alpha(2)-adrenoceptors: cellular and functional characterization". The Journal of Pharmacology and Experimental Therapeutics. 297 (3): 876–887. PMID 11356907. Archived from the original on 2019-12-14. Retrieved 2013-08-21.
Gobert A, Di Cara B, Cistarelli L, Millan MJ (April 2003). "Piribedil enhances frontocortical and hippocampal release of acetylcholine in freely moving rats by blockade of alpha 2A-adrenoceptors: a dialysis comparison to talipexole and quinelorane in the absence of acetylcholinesterase inhibitors". The Journal of Pharmacology and Experimental Therapeutics. 305 (1): 338–346. doi:10.1124/jpet.102.046383. PMID 12649387. S2CID 29234876.
Crassous PA, Cardinaletti C, Carrieri A, Bruni B, Di Vaira M, Gentili F, et al. (August 2007). "Alpha2-adrenoreceptors profile modulation. 3.1 (R)-(+)-m-nitrobiphenyline, a new efficient and alpha2C-subtype selective agonist". Journal of Medicinal Chemistry. 50 (16): 3964–3968. doi:10.1021/jm061487a. PMID 17630725.
Del Bello F, Mattioli L, Ghelfi F, Giannella M, Piergentili A, Quaglia W, et al. (November 2010). "Fruitful adrenergic α(2C)-agonism/α(2A)-antagonism combination to prevent and contrast morphine tolerance and dependence". Journal of Medicinal Chemistry. 53 (21): 7825–7835. doi:10.1021/jm100977d. PMID 20925410.

ncbi.nlm.nih.gov

Arnsten AF (December 2020). "Guanfacine's mechanism of action in treating prefrontal cortical disorders: Successful translation across species". Neurobiology of Learning and Memory. 176: 107327. doi:10.1016/j.nlm.2020.107327. PMC 7567669. PMID 33075480.
Sagrada A, Fargeas MJ, Bueno L (August 1987). "Involvement of alpha-1 and alpha-2 adrenoceptors in the postlaparotomy intestinal motor disturbances in the rat". Gut. 28 (8): 955–959. doi:10.1136/gut.28.8.955. PMC 1433140. PMID 2889649.
Qin K, Sethi PR, Lambert NA (August 2008). "Abundance and stability of complexes containing inactive G protein-coupled receptors and G proteins". FASEB Journal. 22 (8): 2920–2927. doi:10.1096/fj.08-105775. PMC 2493464. PMID 18434433.
Young R (2007). "TDIQ (5,6,7,8-tetrahydro-1,3-dioxolo [4,5-g]isoquinoline): discovery, pharmacological effects, and therapeutic potential". CNS Drug Reviews. 13 (4): 405–422. doi:10.1111/j.1527-3458.2007.00022.x. PMC 6494129. PMID 18078426.

ninds.nih.gov

National Institute of Neurological Disorders and Stroke (2002). "Methylphenidate and Clonidine Help Children With ADHD and Tics".

online-medical-dictionary.org

"online-medical-dictionary.org". Archived from the original on 2007-08-24. Retrieved 2007-12-26.

semanticscholar.org

api.semanticscholar.org

Haenisch B, Walstab J, Herberhold S, Bootz F, Tschaikin M, Ramseger R, et al. (December 2010). "Alpha-adrenoceptor agonistic activity of oxymetazoline and xylometazoline". Fundamental & Clinical Pharmacology. 24 (6): 729–739. doi:10.1111/j.1472-8206.2009.00805.x. PMID 20030735. S2CID 25064699.
Gobert A, Di Cara B, Cistarelli L, Millan MJ (April 2003). "Piribedil enhances frontocortical and hippocampal release of acetylcholine in freely moving rats by blockade of alpha 2A-adrenoceptors: a dialysis comparison to talipexole and quinelorane in the absence of acetylcholinesterase inhibitors". The Journal of Pharmacology and Experimental Therapeutics. 305 (1): 338–346. doi:10.1124/jpet.102.046383. PMID 12649387. S2CID 29234876.

unc.edu

pdsp.med.unc.edu

Roth BL, Driscol J (12 January 2011). "PDSP K_i Database". Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Archived from the original on 8 November 2013. Retrieved 27 November 2013.

web.archive.org

Millan MJ, Cussac D, Milligan G, Carr C, Audinot V, Gobert A, et al. (June 2001). "Antiparkinsonian agent piribedil displays antagonist properties at native, rat, and cloned, human alpha(2)-adrenoceptors: cellular and functional characterization". The Journal of Pharmacology and Experimental Therapeutics. 297 (3): 876–887. PMID 11356907. Archived from the original on 2019-12-14. Retrieved 2013-08-21.
Roth BL, Driscol J (12 January 2011). "PDSP K_i Database". Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Archived from the original on 8 November 2013. Retrieved 27 November 2013.
"online-medical-dictionary.org". Archived from the original on 2007-08-24. Retrieved 2007-12-26.

webmd.com

"Clonidine Oral Uses". Web MD.